---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-22-043040"
form_type: "8-K"
ticker: "ROIV"
cik: "0001635088"
company_name: "Roivant Sciences Ltd."
filed_at: "2022-11-23T23:59:59+00:00"
generated_at: "2026-06-21T13:26:05.730577+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Andrew Lo resigns from Roivant Sciences board effective Nov 17, 2022

## Summary
- Dr. Andrew Lo, Class II director, resigned to focus on other ventures; no disagreement with company.
- Resignation effective November 17, 2022.
- Board expressed gratitude for Dr. Lo's years of service.

## SEC filing metadata
- accession: 0001140361-22-043040
- form_type: 8-K
- ticker: ROIV
- cik: 0001635088
- company_name: Roivant Sciences Ltd.
- filed_at: 2022-11-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1635088/000114036122043040/0001140361-22-043040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1635088/000114036122043040/brhc10044578_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-22-043040
- JSON: https://secwatch.observer/filing/0001140361-22-043040.json
- Plain text: https://secwatch.observer/filing/0001140361-22-043040.txt

## Key facts
- Executive change
  Andrew Lo resigned as Class II director at Roivant Sciences Ltd..
  - Action: resigned
  - Role: Class II director
  source text: On November 17, 2022, Dr. Andrew Lo, a Class II director of Roivant Sciences Ltd. (the “Company”), informed the Company of his decision to resign from his role on the Company’s board of directors (the “Board”) effective immediately, to focus on other ventures.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1635088/000114036122043040/0001140361-22-043040-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.